Yahoo Finance25d
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
Dr. Howard Lee, Chairman and CEO of TAHO Pharmaceuticals, stated, "This pivotal study underscores our commitment to patient-centric innovation. TAH3311 is especially valuable for stroke patients ...
Yahoo Finance25d
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAH3311 dissolves rapidly in the mouth without water, providing a more convenient alternative to tablets. Dr. Howard Lee, Chairman and CEO of TAHO Pharmaceuticals, stated, "This pivotal study ...